These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23092808)

  • 41. Applying usability heuristics to radiotherapy systems.
    Chan AJ; Islam MK; Rosewall T; Jaffray DA; Easty AC; Cafazzo JA
    Radiother Oncol; 2012 Jan; 102(1):142-7. PubMed ID: 21733590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reducing medication errors and increasing patient safety: case studies in clinical pharmacology.
    Benjamin DM
    J Clin Pharmacol; 2003 Jul; 43(7):768-83. PubMed ID: 12856392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preventing blood transfusion failures: FMEA, an effective assessment method.
    Najafpour Z; Hasoumi M; Behzadi F; Mohamadi E; Jafary M; Saeedi M
    BMC Health Serv Res; 2017 Jun; 17(1):453. PubMed ID: 28666439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A method for evaluating quality assurance needs in radiation therapy.
    Huq MS; Fraass BA; Dunscombe PB; Gibbons JP; Ibbott GS; Medin PM; Mundt A; Mutic S; Palta JR; Thomadsen BR; Williamson JF; Yorke ED
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S170-3. PubMed ID: 18406920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introducing a change in hospital policy using FMEA methodology as a tool to reduce patient hazards.
    Ofek F; Magnezi R; Kurzweil Y; Gazit I; Berkovitch S; Tal O
    Isr J Health Policy Res; 2016; 5():30. PubMed ID: 27822358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and feasibility of STAT RAD: Improvement of a novel rapid tomotherapy-based radiation therapy workflow by failure mode and effects analysis.
    Jones RT; Handsfield L; Read PW; Wilson DD; Van Ausdal R; Schlesinger DJ; Siebers JV; Chen Q
    Pract Radiat Oncol; 2015; 5(2):106-12. PubMed ID: 25413416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel approach to infectious disease control and radiotherapy risk management.
    Islam NM; Wadi-Ramahi SJ; Lalonde R; Baig T; diMayorca M; Clump DA; Huq MS
    Med Phys; 2023 May; 50(5):2683-2694. PubMed ID: 36841994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk analysis of analytical validations by probabilistic modification of FMEA.
    Barends DM; Oldenhof MT; Vredenbregt MJ; Nauta MJ
    J Pharm Biomed Anal; 2012 May; 64-65():82-6. PubMed ID: 22410502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. To err is human: improving patient safety through failure mode and effect analysis.
    Woodhouse S; Burney B; Coste K
    Clin Leadersh Manag Rev; 2004; 18(1):32-6. PubMed ID: 14968751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticipating risk for human subjects participating in clinical research: application of Failure Mode and Effects Analysis.
    Cody RJ
    Cancer Invest; 2006 Mar; 24(2):209-14. PubMed ID: 16537191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A FMEA clinical laboratory case study: how to make problems and improvements measurable.
    Capunzo M; Cavallo P; Boccia G; Brunetti L; Pizzuti S
    Clin Leadersh Manag Rev; 2004; 18(1):37-41. PubMed ID: 14968752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of categorized time-trend reporting of radiation oncology incidents: a proactive analytical approach to improving quality and safety over time.
    Arnold A; Delaney GP; Cassapi L; Barton M
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1548-54. PubMed ID: 20598456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of the global risk analysis in pulsed-dose rate brachytherapy: methods and results.
    Mazeron R; Aguini N; Rivin Del Campo E; Dumas I; Gensse MC; Brusadin G; Lefkopoulos D; Deutsch E; Haie-Meder C
    Cancer Radiother; 2015 Apr; 19(2):89-97. PubMed ID: 25600666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FMEA team performance in health care: A qualitative analysis of team member perceptions.
    Wetterneck TB; Hundt AS; Carayon P
    J Patient Saf; 2009 Jun; 5(2):102-8. PubMed ID: 19920449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of two prospective risk analysis methods: Traditional FMEA and a modified healthcare FMEA.
    Rah JE; Manger RP; Yock AD; Kim GY
    Med Phys; 2016 Dec; 43(12):6347. PubMed ID: 27908165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The management of the risk due to the manual lifting of patients in a hospital risk-management program].
    Margonari M; Nava C; Basilico S; Petri A
    Med Lav; 1999; 90(2):351-61. PubMed ID: 10371825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collection and evaluation of incidents in a radiotherapy department : a reactive risk analysis.
    Portaluri M; Fucilli FI; Gianicolo EA; Tramacere F; Francavilla MC; De Tommaso C; Castagna R; Pili G
    Strahlenther Onkol; 2010 Dec; 186(12):693-9. PubMed ID: 21140128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cause-and-effect analysis of risk management files to assess patient care in the emergency department.
    White AA; Wright SW; Blanco R; Lemonds B; Sisco J; Bledsoe S; Irwin C; Isenhour J; Pichert JW
    Acad Emerg Med; 2004 Oct; 11(10):1035-41. PubMed ID: 15466145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.